Navigation Links
Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
Date:11/12/2008

ROCKVILLE, Md., Nov. 12 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Lazard Capital Markets 5th Annual Healthcare Conference at 3:00 pm. (EST) on November 19, 2008 at the St. Regis Hotel, New York city. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
2. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
3. Novavax CEO to Present at BIO Investor Forum 2008
4. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
5. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
6. Novavax Announces Closing of $18 Million Registered Direct Offering
7. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
8. Novavax to Join Russell 3000 Index
9. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
10. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
11. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial ... of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The ... percent of these heavily pretreated patients saw clinical benefit from the drug, with ...
(Date:1/11/2017)... ... January 11, 2017 , ... Photonics industry ... photonics , are commending the U.S. Congress and President Obama for their recognition ... President of the American Innovation and Competitiveness Act (AICA). , The language of ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... in clinical settings, it is becoming increasingly clear that the evolution and transmission ... methods, the standard in the study of clinical resistance, has vastly underestimated these ...
(Date:1/11/2017)... ... January 11, 2017 , ... For many fledging startups, ... the challenges young businesses face. With the second installment of Quorum’s newest signature ... Geoff DiMasi, Founder and Principal of interactive design agency, P’unk Ave. , ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
(Date:12/15/2016)... 2016 Advancements in biometrics will ... and wellbeing (HWW), and security of vehicles ... passenger vehicles begin to feature fingerprint recognition, ... beat monitoring, brain wave monitoring, stress detection, ... pulse detection. These will be driven by ...
(Date:12/15/2016)... LONDON , Dec. 14, 2016 "Increase ... mobile biometrics market" The mobile biometrics market is expected ... USD 49.33 billion by 2022, at a CAGR of ... by factors such as the growing demand for smart ... mobile transactions. "Software component is expected to ...
Breaking Biology News(10 mins):